ArticleEuropean journal of clinical nutrition2026
The impact of ready-to-use-therapeutic-food (RUTF) on micronutrient levels in undernourished children with cancer: a randomized open-labelled controlled study.
Article in European journal of clinical nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEmerging evidence suggests that micronutrient deficiencies are predictive of poorer outcomes in children with cancer. We assessed the prevalence and clinical impact of circulating micronutrient concentrations, as well as the change in micronutrient status after RUTF supplementation, in undernourished children with cancer.
methodsUndernourished children with cancer were randomized 1:1 to receive either standard nutritional therapy(SNT) or SNT + RUTF for 6 weeks. The primary outcome was weight gain, and secondary outcomes included changes in micronutrient status from study entry to 6 weeks, including serum copper, phosphorus, zinc, iron, B12 and 25-OH vitamin D3. Predefined laboratory reference cut-offs for low circulating micronutrient concentrations were applied. Clinical outcomes assessed were significant infection, grade 3-4 mucositis and treatment delay >1 week.
resultsBetween July-2015 and March-2018, 260 subjects were enrolled; 191 (76.7%) had low circulating concentrations of at least one micronutrient and 37 (14.9%) low circulating concentrations of 3 or more micronutrients. Low circulating concentrations were noted with vitamin D3-111 (42.7%), serum zinc in 97 (37.3%), phosphorus-62 (23.8%) and iron-45 (18%). Fewer children who received RUTF-34 (27.6%) had low zinc concentrations compared to SNT-45 (35.7%, p = 0.045) and 35 (25.5%) had improvement in vitamin B12 concentrations compared to SNT-23 (18.3%, p = 0.045). Irrespective of treatment arm, low circulating zinc and copper at study entry were associated with treatment delay (OR 1.8; 95% CI 1.1-3.2 and OR 4.7; 95% CI 0.4-53.2, respectively). Low circulating vitamin B12 was associated with toxic death (OR 9.7; 95% CI 2.4-38.8).
conclusionsThere is a high prevalence of low circulating micronutrient concentrations, specifically vitamin D3, zinc, phosphorus and iron in children with cancer, often associated with adverse clinical outcomes. Supplementation with RUTF showed an inconsistent improvement in micronutrient levels. The clinical impact of micronutrient deficiencies in children with cancer should be the focus of future interventional trials. There is a need for evidence-based micronutrient supplementation in children with cancer.
Identifiers
42711396What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.